Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
52.04
+1.06 (2.08%)
At close: Oct 7, 2025, 4:00 PM EDT
51.70
-0.34 (-0.65%)
After-hours: Oct 7, 2025, 5:02 PM EDT
PRAX Stock Forecast
Stock Price Forecast
The 10 analysts that cover PRAX stock have a consensus rating of "Strong Buy" and an average price target of $93.3, which forecasts a 79.29% increase in the stock price over the next year. The lowest target is $28 and the highest is $163.
Price Target: $93.3 (+79.29%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for PRAX stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Buy | 3 | 4 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 11 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jones Trading | Jones Trading | Strong Buy Initiates $83 | Strong Buy | Initiates | $83 | +59.49% | Sep 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $105 → $115 | Strong Buy | Maintains | $105 → $115 | +120.98% | Aug 5, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $80 | Strong Buy | Maintains | $80 | +53.73% | Jul 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $105 | Strong Buy | Reiterates | $105 | +101.77% | Jul 18, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $97 → $115 | Buy | Maintains | $97 → $115 | +120.98% | Jul 8, 2025 |
Financial Forecast
Revenue This Year
93.50K
from 8.55M
Decreased by -98.91%
Revenue Next Year
112.20K
from 93.50K
Increased by 20.00%
EPS This Year
-13.63
from -10.21
EPS Next Year
-12.60
from -13.63
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.2M | 1.2M | |||
| Avg | 93,503 | 112,200 | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -86.5% | 1,135.2% | |||
| Avg | -98.9% | 20.0% | |||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -13.09 | -6.20 | |||
| Avg | -13.63 | -12.60 | |||
| Low | -14.34 | -17.62 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.